“Efficacy of Rosuvastatin Vs Atorvastatin in High Risk Dyslipidemic Patients”. Physical Education, Health and Social Sciences, vol. 3, no. 2, June 2025, pp. 916-22, https://doi.org/10.63163/jpehss.v3i2.454.